N8 Medical

N8 Medical, LLC, a clinical-stage medical device company, is at the forefront of commercializing innovative medical devices enhanced with a novel class of active compounds known as ceragenins. N8 Medical’s goal is to revolutionize the safety of indwelling medical devices and implants. By applying its innovative CeraShield™ properties to these devices, the company aims to prevent Hospital-Acquired Infections (HAIs), thereby reducing the reliance on antibiotics and combating Antimicrobial Resistance (AMR).

The company's lead medical device is the CeraShield Endotracheal Tube, which the FDA has designated as a “breakthrough device” and is approved for routine clinical use in Canada and other countries.